. . . Meditation - EEG/fMRI Biofeedback - Psychedelics . . .
Among the first trials are psilocybin for anorexia nervosa and psilocybin for psychological distress and cognitive impairment in early Alzheimer’s disease.
No comments:
Post a Comment